Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lantern Pharma Inc (LTRN)

Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lantern Pharma Inc 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 USA

www.lanternpharma.com P: 972-277-1136

Description:

Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.

Key Statistics

Overview:

Market Capitalization, $K 59,067
Enterprise Value, $K 37,127
Shares Outstanding, K 10,759
Annual Sales, $ 0 K
Annual Net Income, $ -15,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,190 K
EBIT, $ -17,880 K
EBITDA, $ -18,040 K
60-Month Beta 1.57
% of Insider Shareholders 6.92%
% of Institutional Shareholders 28.62%
Float, K 10,014
% Float 93.08%
Short Volume Ratio 0.32

Growth:

1-Year Return 31.97%
3-Year Return -64.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.39 on 03/18/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.48
EPS Growth vs. Prev Qtr -34.48%
EPS Growth vs. Prev Year -25.81%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LTRN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -34.11%
Return-on-Assets % -32.19%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.36
Book Value/Share 3.76
Interest Coverage -1.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar